The pharmaceutical industry has come under attack for many reasons: the high cost of drugs, a strong stand against drug re-importation, biased clinical trials, and direct advertising to consumers, to name a few. Once considered a respected partner to medical schools and medical education, pharmaceutical companies are now being shunned by academic medical centers. Some medical schools have restricted or prohibited interactions between pharmaceutical representatives and residents and students (1). The role of the pharmaceutical industry in medical education is one of the most widely contested issues in medical practice today. In psychiatry, the debate has reached a fevered pitch, in part because psychiatric disorders have become ripe for "condition branding" (2), while efforts to counteract the pervasive influence of the pharmaceutical industry have not always been successful. Economist Kevin Hassett perceives the war against the pharmaceutical industry second only to the war on terror (3). On one hand, staunch industry opponents are calling for a "cease and desist" of all pharmaceutical educational activitieslunch n learn, grand rounds, continuing medical education (CME) symposia, and other eventsand for professional organizations and academic institutions to refuse drug funding for such activities. The rationale is that all educational activities sponsored by
The Role of the Pharmaceutical Industry in Medical Education in Psychiatry
Abstract
The pharmaceutical industry has come under attack for many reasons: the high cost of drugs, a strong stand against drug re-importation, biased clinical trials, and direct advertising to consumers, to name a few. Once considered a respected partner to medical schools and medical education, pharmaceutical companies are now being shunned by academic medical centers. Some medical schools have restricted or prohibited interactions between pharmaceutical representatives and residents and students (1). The role of the pharmaceutical industry in medical education is one of the most widely contested issues in medical practice today. In psychiatry, the debate has reached a fevered pitch, in part because psychiatric disorders have become ripe for "condition branding" (2), while efforts to counteract the pervasive influence of the pharmaceutical industry have not always been successful. Economist Kevin Hassett perceives the war against the pharmaceutical industry second only to the war on terror (3). On one hand, staunch industry opponents are calling for a "cease and desist" of all pharmaceutical educational activitieslunch n learn, grand rounds, continuing medical education (CME) symposia, and other eventsand for professional organizations and academic institutions to refuse drug funding for such activities. The rationale is that all educational activities sponsored byPreview Only. This article cannot be rented because we do not currently have permission from the publisher.
/lp/american-psychiatric-publishing-inc-journal/the-role-of-the-pharmaceutical-industry-in-medical-education-in-A8BC407YIC
Welcome to DeepDyve! Rent Premier Research Articles and Save Up to 90%
Preview Only
The Role of the Pharmaceutical Industry in Medical Education in Psychiatry
Lazarus, Arthur
Follow Academic Psychiatry
, Volume 30 (1): 40
American Psychiatric Publishing, Inc (Journal) – Feb 1, 2006
More Info
More Like This Article
View All dataSource[]=actageo&dataSource[]=aspet&dataSource[]=aaos&dataSource[]=aacc&dataSource[]=aacr&dataSource[]=aea&dataSource[]=aip&dataSource[]=ajnr&dataSource[]=ams&dataSource[]=aps_physical&dataSource[]=appi_book&dataSource[]=appi_journal&dataSource[]=apha&dataSource[]=asip&dataSource[]=asm&dataSource[]=asn&dataSource[]=aspb&dataSource[]=avs&dataSource[]=annual_reviews&dataSource[]=arxiv&dataSource[]=acm&dataSource[]=berghahn&dataSource[]=cabi&dataSource[]=clinical_trials&dataSource[]=dailymed&dataSource[]=degruyter&dataSource[]=du_press&dataSource[]=esa&dataSource[]=eu_press&dataSource[]=elsevier&dataSource[]=emerald&dataSource[]=ejtr&dataSource[]=emea&dataSource[]=epo&dataSource[]=faseb&dataSource[]=gsa&dataSource[]=health_affairs&dataSource[]=hindawi&dataSource[]=imanager&dataSource[]=imedpub&dataSource[]=informa_healthcare&dataSource[]=informs&dataSource[]=iop&dataSource[]=iucr&dataSource[]=iospress&dataSource[]=jbjs&dataSource[]=leftcoast&dataSource[]=lu_press&dataSource[]=mesharpe&dataSource[]=mary_ann_liebert&dataSource[]=medline&dataSource[]=mit_press&dataSource[]=nature&dataSource[]=oxford&dataSource[]=pier_professional&dataSource[]=pnas&dataSource[]=portlandpress&dataSource[]=psyc_articles&dataSource[]=psyc_books&dataSource[]=psyc_critiques&dataSource[]=plos_journal&dataSource[]=pubmed_central&dataSource[]=rsna&dataSource[]=rockefeller&dataSource[]=rcn&dataSource[]=ria&dataSource[]=rsc&dataSource[]=sage&dataSource[]=spie&dataSource[]=springer_journal&dataSource[]=springer&dataSource[]=taylor_francis&dataSource[]=aps&dataSource[]=the_scientist&dataSource[]=uc_press&dataSource[]=uspto_abstract&dataSource[]=wiley&dataSource[]=pct
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy
